drugset / Trial / NCT06005714
Effect of Pharmacokinetics in Healthy Chinese Subjects
Non-randomizedCrossoverOpen-labelOther
Summary
This study is a single-center, open label, self-controlled phase I clinical study, to evaluate the effects of clarithromycin or cyclosporine on pharmacokinetics of deuterium hydrobromide ramidvir tablets in healthy Chinese subjects.
Timeline
- Start
- 2023-08-15
- Primary completion
- 2023-10-31
- Completion
- 2023-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clarithromycin | Small molecule | — | — |
| Subject | Cyclosporine | Peptide | — | — |
| Subject | REMIDEVIR | Small molecule | — | — |
Indications
No indication recorded.